Roledumab

Roledumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetRHD
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 X markNcheckY (what is this?)  (verify)

Roledumab is a monoclonal antibody. It binds to RHD, the Rhesus factor antigen.[1][2]

It is currently at Phase III trials for Rh disease.

References

  1. ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 103" (PDF). WHO Drug Information.
  2. ^ Kaplon H, Reichert JM (2018). "Antibodies to watch in 2018". mAbs. 10 (2): 183–203. doi:10.1080/19420862.2018.1415671. PMC 5825203. PMID 29300693.


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by adding missing information.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.